+1-800-553-0977 or +1 215-253-5777
Halo Labs is a venture-backed scientific instrumentation and consumable company that commercializes high-throughput biopharmaceutical formulation and quality control tools for particle analysis using state-of-the-art custom optics and image processing techniques.
Halo Labs knows particles. The Aura, our flagship product, can count and characterize subvisible particles – and tell you whether they are proteinaceous or non-proteinaceous. A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.
Halo Labs’ core mission has been to provide researchers with unprecedented insights into the particles present in their processes by leveraging our core scientific competency: optical imaging on membranes. Over the years, Halo Labs has been the recipient of many prestigious awards, and has received over $6M in research grants from agencies including DARPA, FDA, NSF, NIST and NIH. Today, we dedicate our collective experience and novel technology to empower formulation researchers to learn more about the stability and quality of their biological drugs faster and with more accuracy than ever before.
Our institutional partners include Research Corporation Technologies (RCT), BioAdvance, Broad Oak Capital Partners, and Ben Franklin.